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Abstract
Background: Vitamin D has a central role in neuronal, reproductive, autoimmune, infectious, and heart diseases. Female Pattern 
Hair Loss (FPHL) is described as a non-scarring, progressive thinning of the hair resulting from a decreasing ratio of terminal hairs 
to thinner vellus hairs. 
Aim: To explore the possibility of vitamin D deficiency contribution to hair loss in women in the local population in West Midlands 
England. 
Method: Records of women from different age groups who were treated in the dermatology outpatient clinic for any skin conditions 
and had their vitamin D status assessed as part of their usual care. In this study we also examine the impact of vitamin D levels and 
age on hair loss.
Results: The studies reviewed medical records of 48 patients diagnosed with dermatological conditions. Low levels of vitamin D 
significantly affects the loss of hair (p = 0.046). The odds ratio estimated is 3.545. Our results show that the impact of low vitamin D 
level is significantly prevalent for the age groups 35 - 45 and moderately impacted age group 55 - 65 years. 
Conclusion: Vitamin D has a significant role in hair-loss process, and possibly early correction may have a role in prevention and 
treatment in women aged 35 - 45 year of age. . 
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Introduction
Vitamin D has an important role in skeletal health. It is known 
to have a central role in neuronal, reproductive, autoimmune, infec-
tious, and heart diseases [1]. There are two sources of this vitamin; 
exogenous from dietary consumption and endogenous, produced 
after the skin has been exposed to solar ultraviolet radiation, es-
pecially UVB [2]. Vitamin D2 is derived from ergosterol after ul-
traviolet irradiation, while 7-dehydrocholesterol (Provitamin D3) 
converts into previtamin D3 after UVB exposure through the skin 
[3]. The next step is ἀ-hydroxylation which occurs in many organs 
including the kidney. Finally, the active form, calcitriol (1,25-dihy-
droxycholecalciferol) is produced in the liver [4].
Female Pattern Hair Loss (FPHL) is described as a non-scarring, 
progressive thinning of the hair resulting from a decreasing ratio of 
terminal hairs to thinner vellus hairs. The process is described as 
follicular miniaturisation [5]. The typical presentation is a diffuse 
loss of hair density, primarily over the vertex, but occipital areas 
may be involved [6]. It is the most frequent cause of hair loss and a 
major cause for referral to a specialist dermatology service in the 
UK. The pathophysiology of FPHL is unclear and appears to be mul-
tifactorial. Although the contributions of a combination of andro-
gens and genetic susceptibility in male androgenic alopecia (AGA) 
are well accepted, the degree to which these factors contribute to 
FPHL is less clear [7]. The condition is common and in Caucasian fe-
males the incidence increases with age. Norwood reported a preva-
lence of 19% in a series of almost 1000 cases [8]. The prevalence 
increases post-menopause. In Norwood’s series, 29% of patients 
over 70 year had the condition [8]. Other studies have reported up 
to 38% in older Caucasians [6] whilst the incidence appears lower 
(around 5 - 7%) in Asian women [9,10].
AGA has a similar presentation to FPHL with miniaturised hair 
follicles; however, the role of androgens in females remain poorly 
understood [6]. Hamilton introduced the concept of androgen in-
volvement in male pattern baldness noting that AGA never occurs 
in males who have never progressed through puberty, and that 
its progression stopped in men who were castrated [11]. He also 
noted that men receiving testosterone replacement therapy were 
prone to balding. AGA was subsequently described to be a conse-
quence of the direct effects of dihydrotestosterone (DHT) on the 
dermal papilla of susceptible hair follicles [12]. DHT is a metabolite 
of testosterone, that binds to androgen receptors in hair follicles. 
This causes upregulation of the genes responsible for the transfor-
mation of terminal hair follicles to miniaturized hair follicles [13].
A similar process has been suggested in the development of 
FPHL. This is supported by the observation that women with hy-
perandrogenism can develop early-onset FPHL [14]. However, 
most patients with FPHL exhibit no other signs or symptoms of 
hyperandrogenism and have normal androgen levels, suggesting a 
different cause. The age-related increase in FPHL suggests oestro-
gen may be a factor [6].
Vitamin D status was identified as an important contributory 
factor in FPHL in the reviewed studies, however it remains unclear 
if this result is applicable to the local population, in West Midlands 
England. 
Aim of the Study
To explore the possibility of vitamin D deficiency contribution 
to hair loss in women in the local population, in West Midlands 
England. 
Methods
This study was categorised as surveillance audit. Records of 
women from different age groups who were treated in the derma-
tology outpatient clinic for any skin conditions and had their vita-
min D status assessed as part of their usual care. Vitamin D status 
was assessed by testing serum 25(OH)D levels [15] and was classi-
fied as mild, moderate or severe (Table 1).
Clinic Codes were allocated as “diffuse hair loss”, “hair loss”, 
“hair thinning” and “normal hair state” to all records (Table 2). 
Data was analysed using Microsoft® Excel® and IBM SPSS® ver-
sion 26.
Results
There were total of 48 patients’ records, who have dermatology 
diagnosis, reviewed for vitamin D level test results. Out of those re-
cords there were 31% of all patients’ records classed as having in-
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Vitamin D status Serum 25-hydroxyvitamin D level (nmol/L)
Severe vitamin D deficiency < 12
Vitamin D deficiency 12 - 25
Vitamin D insufficiency 25 - 50
Marginal vitamin D status 50 - 75
Vitamin D sufficiency 75 - 150
Risk of toxicity > 375
Table 1: Staging of vitamin D status used in this study [15].
State Definition
Diffuse Hair Loss Excessive FPHL hair loss
Hair Loss Moderate FPHL hair loss
Hair Thinning Mild FPHL hair loss
Normal hair state Normal hair no hair loss diagnosis
Table 2: Definitions of clinic code used in this study.
sufficient or deficient vitamin D levels where 80% of those had hair 
loss (60% and 20% respectively) and additional 36% with mar-
ginal vitamin D status where 60% of those had hair loss compared 
to 44% of all patients with sufficient vitamin D levels (Figure 1).
Figure 2 demonstrate that hair loss is more prevalent in females 
with suboptimal vitamin D (69% of all patients) than females with 
normal vitamin D (44%).
Using a binary logistic model, we examine the impact of vita-
min D on hair loss. Table 3 shows that low levels of vitamin D sig-
nificantly affects the loss of hair. The odds ratio estimated is 3.545. 
This indicates that vitamin D is likely to play a significant role in 
hair-loss treatment.
In this study we also examine the impact of age on hair loss. 
Table 4 shows that the impact of low vitamin D level is significantly 
prevalent for the age groups 35 - 45 and 55 - 65.
Figure 1: Vitamin D levels and co-occurrence of hair loss.
Figure 2: Comparing hair loss severity in women by vitamin D level status. 
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Discussion
Recent evidence has linked serum 25-hydroxycholecalciferol 
values with FPHL [16]. Monieb reported a low level of serum vi-
tamin D in FPHL patients compared to controls [17]. In this study, 
96.6 % of FPHL patients were shown to have a low level of serum 
vitamin D; only 3.3% were measured within the normal range. A 
significant correlation was found between vitamin D level and the 
severity of FPHL. No link was found between the severity of hair 
loss and duration of the condition, or with the patient’s age [17].
This was confirmed by Rasheed [18] and also Banihashemi 
[19], who also showed a correlation between severity of FPHL and 
lower concentrations of vitamin D, although these studies differed 
in their findings relating to the significance of a positive family his-
tory, which remains controversial [6]. Fawzi [20] identified lower 
Factors Odds Ratio Std. error p-value
Constant 0.846 0.410 0.683





Table 3: Examining the impact of vitamin D on hair loss.
Note: ** represents significance at 5 percent level. The p-value of 
the chi-square test suggests that Low Vitamin D level had a signifi-
cant impact on the dependent variable, i.e. hair loss.
Age Group n Chi-Square Statistic p-value
< 25 5 1.875 0.171
26 - 35 11 0.079 0.778
36 - 45 11 4 0.046**
46 - 55 13 0.782 0.376
56 - 65 7 3 0.083*
> 66 1 1.333 0.248
Table 4: Examining the significance of age.
Note: ** represents significance at 5 percent level and  
* represents significance at 10 percent level.
numbers of vitamin D receptors in patients with both alopecia 
areata and AGA, but a higher concentration in patients with FPHL. 
The possible explanation could be due to the interaction between 
17 beta oestradiol and 1,25 dihydroxycholecalciferol results in 
gene expression enhancement [21].
This study reviewed medical records of 48 patients diagnosed 
with dermatological conditions. In line with previous studies 
[16,17,19,20] a low level of vitamin D was found to have a signifi-
cant link with hair loss, suggesting a role in the causation and or 
pathogenesis of hair loss and thinning processes. That it has been 
identified in AA, AGA and FPHL suggests association rather than 
causation [20]. It is speculated that one factor may be emotional 
distress arising from altered appearance may prevent or reduce 
time spent outdoors [22] reducing exposure to UVB leading to re-
duced production of cholecalciferol. 
However, a limitation is that none of these studies to date has 
accounted for seasonal variations in the level of dihydroxychole-
calciferol [23]. Therefore, it would be an improvement in future 
studies to standardise the season during which the measurements 
of the measurement of the vitamin levels are made. This study sam-
ple, like most of the studies identified, is small and in a localised 
population. It is also becoming clear that in addition to vitamin D 
levels, the number of vitamin D receptors expressed on cells varies 
is altered in various skin conditions [24]. 
Conclusion
This study investigated the relationship between vitamin D lev-
els and one type of hair loss, FPHL. The study showed a significant 
difference in hair loss between all age groups. This study showed 
vitamin D deficiency can be associated with hair loss in pre-meno-
pausal women where the impact is highest for the age groups 35 
- 45 followed by 55 - 65 years old. Whilst it clearly is a factor, there 
is more to be done to fully understand the mechanisms involved.
Highlights
1. Vitamin D deficiency is prevalent in local population, in West 
Midlands England. young females, 45 years of age and young-
er.
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